BiochemistrybioRxivPreprint
Structure-based design of selective salt-inducible kinase (SIK) inhibitors
R. Tesch, M. Rak, M. Raab…·S. Knapp
This study designs a selective SIK inhibitor, MRIA9, based on a PAK inhibitor, showing its dual activity and potential for combination therapy in ovarian cancer.
DOI 10.1101/2021.04.08.439011